U.S. market Closed. Opens in 1 day 6 hours

IOVA | Iovance Biotherapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue1.19MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue10.76M21.14M13.98M8.71M8.12M956.00K952.00K978.00K999.00K9.34M4.66M6.48M19.30MN/AN/AN/A
Gross Profit-9.57M-21.14M-13.98M-8.71M-8.12M-956.00K-952.00K-978.00K-999.00K-9.34M-4.66M-6.48M-19.30MN/AN/AN/A
Operating Expenses450.99M398.88M342.70M261.94M206.87M128.26M92.88M53.64M27.86M12.04M22.64M8.13M21.06M815.41K15.77K57.14K
Selling, General & Admin106.92M104.10M83.66M60.21M40.85M28.43M21.26M25.60M12.39M9.34M4.66M6.48M19.30MN/A14.44K25.56K
Research & Development344.08M294.78M259.04M201.73M166.02M99.83M71.61M28.04M15.47M2.70M1.33M1.66M1.76MN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A16.66MN/A19.30M815.41K15.77K57.14K
Operating Income-460.56M-398.88M-342.70M-261.94M-206.87M-128.26M-92.88M-53.64M-27.86M-12.04M-22.64M-8.13M-21.22M-815.41K-15.77K-57.14K
Other Expenses / Income13.04M2.98M451.00K2.36M9.32M4.68M813.00K745.00K200.00K5.66K-2.74M4.82M-4.48M-792.58KN/AN/A
Before Tax Income-447.52M-395.89M-342.25M-259.58M-197.56M-123.58M-92.06M-52.89M-27.66M-12.03M-25.38M-3.31M-25.69M-1.61M-15.77K-57.14K
Income Tax Expenses-3.48M-5.97M-14.43M-2.36M-10.48M4.68M-952.00K-978.00K-999.00KN/A444.73K2.42M4.64M792.58KN/AN/A
Net Income-444.04M-389.92M-327.82M-257.23M-187.07M-123.58M-92.06M-52.89M-27.66M-12.03M-25.38M-3.31M-25.69M-1.61M-15.77K-57.14K
Interest ExpensesN/A2.98MN/AN/AN/AN/AN/AN/A200.00K5.66K444.73K2.42M151.51KN/AN/AN/A
Basic Shares Outstanding235.13M159.26M153.41M138.30M124.34M97.28M65.24M55.27M44.41M24.99M9.76M798.53K759.24K652.46K381.00K1.21M
Diluted Shares Outstanding235.13M159.26M153.41M138.30M124.34M97.28M65.24M55.27M44.41M24.99M9.76M798.53K759.24K652.46K381.00K1.21M
EBITDA-427.43M-374.76M-328.27M-250.87M-189.43M-122.62M-91.11M-51.92M-26.66M-11.95M-24.93M508.81K-20.54M-1.55M-14.44K-55.81K
EBITDA Margin-35,948.86%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-447.52M-392.91M-342.25M-259.58M-197.56M-118.90M-93.02M-53.87M-28.46M-12.03M-24.49M1.53M-20.91M-815.41K-15.77K-57.14K
EBIT Margin-37,638.02%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙